Does Berberine Help With Berberine demonstrates modest but significant reductions ...?

Evidence Summary

Berberine demonstrates modest but significant reductions in LDL cholesterol, apolipoprotein B, and high-sensitivity CRP in individuals with obesity and MASLD (PMID: 41543854). It shows durable protective effects against colorectal adenoma recurrence, with benefits persisting at least 6 years post-treatment (PMID: 40795846). It also appears to improve vascular function markers including VEGF in MAFLD patients (PMID: 41305635) and may ameliorate cholestatic liver disease via gut microbiota-mediated conversion to dihydroberberine (PMID: 41087029).

Source: auto-research

Effective Dose

1000-1500 mg/day based on clinical trial doses